OBJECTIVE: To develop a simple and easy-to-use tool for identifying osteoporotic women (femoral neck bone mineral density [BMD] Tscores À 2.5) in Latin America.
M
any publications have reported that osteoporosis is underdiagnosed and that only a small proportion of patients are appropriately treated. [1] [2] [3] The prevalence of osteoporosis varies among Latin American countries. In Mexico, the prevalence of osteoporosis among women 50 and over is between 16% and 30%, 4 while in Chile, osteoporosis prevalence was estimated to be 22% and 29.2% in women older than 50 and all postmenopausal women, respectively. 5, 6 In Brazil 10 million people (1 out of 17 persons) have osteoporosis, 7 while in Venezuela, only 10% of the population older than 70 have normal bone mass. 8 Earlier studies reported lower hip fracture rates in Latin America than in U.S. or European whites. [9] [10] [11] [12] However, the number of women at risk of osteoporosis and hip fracture is increasing in Latin America. The number of hip fractures for women and men aged 50-64 in Latin America will increase by 400%, while in ages 65 and over the increase will be a staggering 700% in 2050 as compared to the prevalence in 1950. 13 Although patients with fracture should automatically be considered for treatment for osteoporosis, and assessment of bone mineral density (BMD) using dual energy x-ray absorptiometry (DXA) is the standard for diagnosing osteoporosis prior to fracture, facilities for DXA measurements remain limited in Latin America and certain other parts of the world, and this poses a serious challenge for diagnosing osteoporosis in patients without prior fracture.
Some researchers have examined the relationship between clinical variables and bone mass in the hope of targeting BMD measurements to patients who are more likely to have osteoporosis. [14] [15] [16] [17] [18] [19] [20] Lydick et al. 17 developed a model that accurately identifies 90% of subjects with low bone mass and 40% of subjects with normal bone mass. Recently, Koh et al. 18 developed an index, the Osteoporosis Self-assessment Tool for Asians (OSTA), for identifying women at increased risk of osteoporosis in a population of Asian patients other than Japanese. The OSTA is based only on age and weight and achieved a sensitivity of 91% for identifying women with osteoporosis; it was further validated in a cohort of Japanese women, with a sensitivity of 98%. 19 The Osteoporosis Self-assessment Tool (OST) was derived from the OSTA by altering the risk category ranges, and performed well in identifying women at risk of osteoporosis in Europe and the United States (sensitivity, 88%; specificity, 52%). 20 The OST is simple and easy to use, because only 2 risk factors are involved (age and weight). Moreover, the OST performs consistently in different white populations. 20, 21 We hypothesized that some adjustment might be necessary to make these instruments applicable to Latin American women. First, risk for osteoporosis varies with racial category. [22] [23] [24] The racial make-up of Latin American populations is very different from the rest of the world. For example, the racial category Mestizo, only present in Latin America, represents a complex and dynamic mixture of white and Native American inhabitants dating from the 16th century. This racial category may vary from having very dominant white characteristics to very dominant Native American characteristics. 25 28 Other risk factors, currently known or unknown, might also influence the performance of existing osteoporosis risk tools in Latin America. Considering these factors, a risk assessment tool specifically developed for Latin American populations might be most appropriate. To assist clinicians in identifying patients for BMD measurements, the current study aimed to develop an osteoporosis risk assessment tool for Latin American populations using easy and widely available risk factors.
METHOD
This was a retrospective study using data from 6 Latin American countries, Argentina, Brazil, Costa Rica, Mexico, Peru, and Venezuela. One osteoporosis clinic with a BMD facility was identified in each of these 6 countries. Records of the most recent 300 postmenopausal women aged 50 and above who had femoral neck DXA measured at these osteoporosis clinics and met exclusion and inclusion criteria were reviewed. These patients were either consulting spontaneously or referred by their physicians for a BMD measurement. The aim was to have at least 200 patients per country so that the primary ethnic variation in each country was captured. Women were considered postmenopausal if they had been amenorrheic with or without other climacteric symptoms for 6 months or more prior to the BMD measurement. The brand of DXA manufacturer varied among centers, and included Norland, Hologic, and Lunar machines.
Because the objective of the study was to develop an osteoporosis risk assessment tool for average postmenopausal women, certain study exclusion criteria were used in order to minimize the potential effect of confounding factors on the risk of being osteoporotic. Women were excluded from the study if they had a history or evidence of metabolic bone disease (other than postmenopausal bone loss); presence of cancer(s) with known metastasis to bone; history of significant renal impairment (serum creatinine level42.5 mg/dl); one or both ovaries removed; history of fracture or replacement of both hips; or history of bisphosphonate, fluoride, or calcitonin use. All data were collected by reviewing patients' medical records that had been documented during their BMD measurement visit to obtain information for the following variables: country of origin, clinical center, BMD values and T-scores at the femoral neck, estrogen use, thyroid use, history of any fracture after 45 years of age, ethnicity, age, height, and body weight. Height and body weight had been measured and documented in the medical records by a clinician at the time of BMD measurement. History of fracture, ethnicity, age, and estrogen and thyroid use had been self-reported by the patients during the same visit.
Data Analysis
Based on World Health Organization (WHO) guidelines, osteoporosis was defined as a BMD value that is 2.5 standard deviations or more below the peak BMD for premenopausal women of the same ethnic origin at that bone site, 29 obtained from reference data provided by each DXA manufacturer. Analysis was performed in two stages: first to identify risk factors with mutually independent associations, and then to develop a simple index from these variables, reducing the number of variables to as few as possible while retaining good performance.
Multivariate Analyses
Multiple least square regression analysis was used to develop a parsimonious model predicting BMD T-scores using standard statistical techniques such as R 2 and forward stepwise model selection. 30, 31 The potential risk factors included in the model development process consisted of the risk factors identified by Koh et al. 18 in the OSTA study: age, weight, history of estrogen use, history of thyroid hormone use, history of fracture since age 45, ethnicity, and country of residence. Additionally, height and BMI were also included in the initial pool of predictors, because several osteoporosis guidelines include BMI as a risk factor for osteoporosis. 32 Also, the Latin American population is highly heterogeneous with respect to height and ethnicity, and height or BMI may potentially contribute to the variance in BMD.
Development of the OsteoRisk Index
The following method was used to develop a risk index for osteoporosis from the regression coefficients of the statistical model. Regression coefficients of age and body weight were multiplied by 10 so that the age and weight variables are in units of 10 years and 10 kilograms. Because weight was the strongest predictor of a woman's T-score and had the smallest coefficient of variance, the regression coefficients for other predictors were divided by the coefficient for body weight, and then multiplied by 2 and rounded to the nearest integer to produce the statistical weights used in calculating the index. Each variable was then multiplied by the statistical weight, and the results were summed to calculate the index. This index was further simplified by dropping variables one at a time beginning with the last variable that had been identified using forward stepwise selection, and working backward while calculating specificity and sensitivity each time to retain good performance (defined here as sensitivity ! 85% and specificity ! 40%). Sensitivity is the proportion of women with osteoporosis (T-score À 2.5) that tested positive (true positives). Specificity is the proportion of women without osteoporosis who tested normal (true negatives). Receiver operating characteristic (ROC) curves and the associated area under the curve (AUC) were used to describe how well various levels of the index can distinguish low bone mass women from those with non-low bone mass. 33 A tool with perfect performance would have an ROC curve near the upper left corner of the plot and an AUC of 1.0, whereas a tool with no value would have an ROC curve directly on the diagonal between the lower left and upper right corners and an AUC of 0.5. Tests are generally considered to have good performance if the AUC is greater than 0.7.
The risk index range corresponding to a sensitivity of $ 90% was chosen to define the low-risk group; the index ranges for the medium-and high-risk groups were chosen such that the prevalence of osteoporosis in the high-risk group was $ 60%; this same process was used in developing previous risk tools. 18, 20 A graphical representation of the risk assessment tool was then developed to simplify clinical use. The sensitivity and specificity of the developed risk assessment tool were further assessed in each of the 6 countries using the development cohort from the respective country in order to check the instrument's consistency of performance across countries.
Validation
The OsteoRisk index was validated using 2 widely accepted methods. First, the risk factors identified as the most useful predictors for BMD in least square regression were compared to those identified as predictors of osteoporosis (T-score o =À 2.5) using a different statistical method, logistic regression. Second, we assessed the performance in a different sample of 279 postmenopausal women age ! 50 in Brazil, with the same inclusion and exclusion criteria as the developmental study. To assess performance of the index, sensitivity and specificity were calculated, an ROC curve was plotted, and the AUC was calculated.
RESULTS

Sample Characteristics
Bone mineral density and records were available for 1,547 women who met the inclusion criteria; Table 1 describes the demographic and clinical characteristics of the sample. There were significant differences among the countries for all variables. Approximately 44% of the women reported they were white, and the remainder Mestizo. The mean age was 65 years, and the mean weight was 63 kg. The mean BMD T-score was À 1.8, with nearly one third of the women (32.5%) being osteoporotic, defined as a BMD T-score À 2.5, and 6.4% had a history of fracture. Table 2 presents the final regression model for predicting T-scores after going through the model selection process. The variables considered in the model were age, weight, height, race, country, history of estrogen use (yes/no), history of thyroid use (yes/no), and history of fractures (yes/no). The results indicate that of these variables, body weight had the greatest explanatory power. In the process of forward selection of the model, body weight entered the model first, alone explaining 20% of variation in BMD T-scores (R 2 =.20). The most complete model containing all significant variables had an R 2 of .42.
Model Selection
Development of the Index
The model with all 8 variables yielded a sensitivity of 91% and specificity of 46% for identifying women with osteoporosis.
The AUC for the model based on all variables was 0.83. After dropping variables one at a time to meet the prespecified performance criteria (defined as sensitivity485% and specificity440%), the simplest model contained only age and body weight; based on this model, the OsteoRisk index is calculated as 0.2 Á [(body weight in kg) À (age in years)].
The final OsteoRisk index ( 1 vs41) had a sensitivity of 92.0% and specificity of 44.7%. The AUC was 0.82, which is generally considered good for a risk assessment tool. Assessment of OsteoRisk's performance separately in each of the 6 countries yielded sensitivity in the range of 84% to 100% and specificity in the range of 35% to 54%, indicating consistent performance of OsteoRisk in identifying osteoporotic women across the countries where it was developed. The prevalence of osteoporosis increased with OsteoRisk category. The low-risk category (OsteoRisk41) represented 33% of all women; only 8% of the women in this category had osteoporosis. The prevalence of osteoporosis was 66% among the group at high risk (OsteoRisk o À 2), which represent 30% of all women. In the intermediate-risk group ( À 2oOsteoRisk 1, 37% of all women), 27% of the patients had osteoporosis (see Fig. 1 ).
Validation
Use of Different Statistical Technique. Use of logistic regression with backward selection process identified age, body weight, estrogen use, and history of fracture as significant predictors. This is very congruent with the results of the least square regression method. Further, a risk index developed based on odds ratios for these significant predictors yielded a similar level of sensitivity (91%) and specificity (53%) as the risk index developed with regression coefficients of the significant predictors from the ordinary least square regression. When the 
DISCUSSION AND CONCLUSION
To our knowledge no osteoporosis index exists for Latin America in the literature except for a clinical index specifically developed for Mexican women in Mexico City, which did not provide sufficient detail to allow comparison here. 34 Given the cultural and racial variations across Latin America, it would be desirable to have an index that is generalizable to the entire Latin American region. The OsteoRisk, based on weight and age, is a simple and easy-to-use osteoporosis risk assessment tool that addresses this need. The primary purpose of such a tool is to identify patients at risk of osteoporosis, among whom BMD can then be used to obtain a definitive diagnosis. The use of 3 risk categories provides a useful alternative to a single cutoff approach when there is a spectrum of risk, as with osteoporosis. Three risk categories have been used in other areas of medicine (blood pressure, serum glucose, and serum cholesterol) to classify low, moderate, and high risk. 18 In our study, 62% of high-risk patients in the developmental sample and 61% of high-risk patients in the Brazilian validation sample had osteoporosis. These findings are almost identical to those reported in similar studies of both white 20, 35 and Asian populations. 18, 19 Patients in this category should undergo BMD measurement and, if positive, should be treated with proven therapies for osteoporosis. However, if access to BMD is very limited, clinicians may consider treating these patients directly for osteoporosis. 18, 36 Almost 27% and 36% of patients in the OsteoRisk medium-risk category had osteoporosis in the developmental sample and validation sample, respectively. These patients should also undergo BMD measurement, followed by treatment if found osteoporotic. It would be reasonable to postpone BMD measurements for patients in the low-risk category, unless major risk factors such as fragility fracture or corticosteroid use are present, which would justify measuring BMD. Both ordinary least square regression and logistic regression identified age and body weight as significant predictors for risk of osteoporosis. The OsteoRisk index, based only on age and weight, performed well in identifying women with osteoporosis. Body weight also showed higher predictive power as compared to BMI. 37 These findings are consistent with earlier studies of white and Asian women that reported that age and weight were important predictors of BMD, and that indices based on age and weight performed as well as models that included additional variables. [18] [19] [20] [21] [22] 35, 38 In fact, the algorithm for calculating OsteoRisk risk for osteoporosis developed in the current study is exactly the same as the algorithm developed independently for the OST and the OSTA, which was originally developed in an Asian cohort and later validated in white cohorts. [18] [19] [20] 35 The OsteoRisk cutoffs for defining high, medium, and low risk are slightly different from those reported for the OST, which may in part reflect ethnic or cultural differences of Latin American versus North American and European populations. These findings demonstrate the external validity of the OST and OsteoRisk in identifying postmenopausal women with osteoporosis and underscore the strong relationship of age and body weight with risk for osteoporosis. Further, OsteoRisk is the only validated osteoporosis risk index available for Latin America. When compared with the performance of other osteoporosis risk indices, OsteoRisk performed well in identifying women at risk of osteoporosis. Table 3 shows a summary of performances of different osteoporosis risk indices in different populations. Combining high-and medium-risk categories, OsteoRisk consistently identified $ 90% or more of patients with osteoporosis (sensitivity), and over 60% of patients in the high-risk category have osteoporosis.
The use of simple risk tools such as the OsteoRisk could yield a sizable cost savings compared with measuring BMD in all postmenopausal women. In the Latin American sample, 33% of the women had OsteoRisk scores greater than 1 (low risk). Koh et al. 18 reported 25% of Japanese women with low risk, and 40% of Asian women. Our study involved a large sample of women from 6 countries located in different parts of Latin America, with varied ethnic distributions that included a large proportion of Mestizo ancestry. The OsteoRisk performed similarly in each country, suggesting that this index could be applicable across Latin America.
As with any retrospective study, this study has some limitations. Only patients who had a BMD measurement were included. The reasons for measuring BMD were not available. Characteristics such as socioeconomic status, health insurance, access to BMD measurement, or other factors might have influenced who would undergo BMD measurement. Further, the prevalence of osteoporosis in this study sample was higher than expected for the general population. All these factors could be sources for potential selection bias. However, this study was conducted in 6 different countries in Latin America and results were consistent across all 6 countries, suggesting that selection bias did not have a large effect on the result.
Although this study included patients from 6 countries in Latin America covering a wide range of ethnicity and race, the study sample primarily included white and Mestizo patients from osteoporosis clinics and relied upon self-report of racial category. The racial category ''Mestizo'' encompasses a wide spectrum of mixture of races ranging from predominantly white to predominantly indigenous. Because 56% of the study sample were Mestizo from 5 countries, this category captured a very heterogeneous racial population, which is a fair reflection of Latin America. However, the study sample did not include any woman of black racial origin. Prior studies observed that risk of osteoporosis is quite different among blacks as compared to other races. 39 Therefore, results from this study may not be applicable to black postmenopausal women. Also, characteristics of Latin Americans who immigrate to other countries might change; additional research would be required to determine how this risk tool would perform in such populations. Additionally, prospective validation testing to evaluate the consistency of performance in different Latin American countries would also be useful. Because local young adult BMD means for these countries were not available, T-scores were calculated using young adult BMD data provided by densitometer manufacturers. The performance of OsteoRisk outside the development cohort was assessed using a Brazilian sample of postmenopausal women. Validation studies in different ethnic populations, particularly among indigenous and black populations in Latin America, are needed to assess OsteoRisk performance in these populations.
OsteoRisk is a simple, easy-to-use tool based on age and weight for identifying Latin American women with osteoporosis. In this sample of women from osteoporosis clinics it accurately identified the vast majority of postmenopausal women with osteoporosis and performed similarly in a sample of women outside the development sample in Latin America. Further validation in other populations such as unselected postmenopausal women is warranted. In the meantime, however, our findings are very consistent with prior studies in other populations of whites and Asians, providing strong external validation. We recommend that patients identified by OsteoRisk as high or medium risk should undergo BMD measurement, and be considered for treatment if BMD is low. 18 Koh et al. 18 Kung et al. 40 Fujiwara et al. 19 Cadarette et al. 41 Sedrine et al. 
